Interfacing exogenous stents with human coronary artery by self-assembled coating: designs, functionalities and applications
Source abstract
Abstract
Abstract Drug-eluting stents are a commonly used treatment for coronary artery disease. However, the coatings used in drug-eluting stents have some limitations such as poor biocompatibility and drug loading capacity. In recent years, self-assembly methods have emerged as a promising alternative for stent coatings. Self-assembled coatings employ biomaterials and offer several advantages over traditional coatings, including thinner thickness, stronger binding capacity, and better biocompatibility. This review discusses the latest research on self-assembled biomaterial-based coatings for drug-eluting stents. We explore how layer-by-layer coatings and composite coating films have been utilized to load and release drugs with high drug loading capacity and biocompatibility, as well as how they promote endothelial adhesion and growth. Additionally, we examine how self-assembled coatings have been used to release active molecules for anti-coagulation and deliver gene therapy. Moreover, we discuss the potential of self-assembled coatings for future development, including intelligent targeted drug delivery, bionic stent coatings, and 3D printed stent coatings. These advancements have the potential to further improve the effectiveness of drug-eluting stents in treating coronary artery disease.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Coronary Interventions and Diagnostics · Anodic Oxide Films and Nanostructures · Polymer Surface Interaction Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. He, Y. et al. The dietary transition and its association with cardiometabolic mortality among Chinese adults, 1982–2012: a cross-sectional population-based study. Lancet Diabetes Endocrinol. 7, 540–548 (2019).10.1016/S2213-8587(19)30152-4 ↗
2. Lv, J. et al. Adherence to healthy lifestyle and cardiovascular diseases in the Chinese population. J. Am. Coll. Cardiol. 69, 1116–1125 (2017).10.1016/j.jacc.2016.11.076 ↗
3. Qi, P., Yang, Y., Maitz, F. M. & Huang, N. Current status of research and application in vascular stents. Chin. Sci. Bull. 58, 4362–4370 (2013).10.1007/s11434-013-6070-1 ↗
4. Zhang, Z. Q., Yang, Y. X., Li, J. A., Zeng, R. C. & Guan, S. K. Advances in coatings on magnesium alloys for cardiovascular stents - A review. Bioact. Mater. 6, 4729–4757 (2021).
5. Nakazawa, G. et al. The Pathology of Neoatherosclerosis in Human Coronary Implants: Bare-Metal and Drug-Eluting Stents. J. Am. Coll. Cardiol. 57, 1314–1322 (2011).10.1016/j.jacc.2011.01.011 ↗
6. Fischman, D. L. et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N. Engl. J. Med. 331, 496–501 (1994).10.1056/NEJM199408253310802 ↗
7. Hou, L.-D. et al. A review on biodegradable materials for cardiovascular stent application. Front. Mater. Sci. 10, 238–259 (2016).10.1007/s11706-016-0344-x ↗
8. Lee, S. J. et al. Heparin coating on 3D printed poly (l-lactic acid) biodegradable cardiovascular stent via mild surface modification approach for coronary artery implantation. Chem. Eng. J. 378, 122116 (2019).10.1016/j.cej.2019.122116 ↗
9. Wang, J. et al. Preparation of the micro/nano structures of the biomimetic coating stent for loading MiRNA126 by four-beam laser interference. Optik 128, 247–252 (2017).10.1016/j.ijleo.2016.10.030 ↗
10. Fischell, D. R., Fischell, T. A., Fischell, R. E., Tepe, G. & Wiskirchen, J. Radioisotope stents. Minim. Invasive Ther. Allied Technol. 11, 149–155 (2002).10.1080/136457002760273359 ↗
11. Meng, S. et al. The effect of a layer-by-layer chitosan-heparin coating on the endothelialization and coagulation properties of a coronary stent system. Biomaterials 30, 2276–2283 (2009).10.1016/j.biomaterials.2008.12.075 ↗
12. Qiu, X. et al. Cellular remodeling of fibrotic conduit as vascular graft. Biomaterials 268, 120565 (2021).
13. Chen, J. L., Li, Q. L., Chen, J. Y., Chen, C. & Huang, N. Improving blood-compatibility of titanium by coating collagen-heparin multilayers. Appl. Surf. Sci. 255, 6894–6900 (2009).10.1016/j.apsusc.2009.03.011 ↗
14. Park, J. et al. Interface Engineering of Fully Metallic Stents Enabling Controllable H2O2 Generation for Antirestenosis. Langmuir 35, 3634–3642 (2019).10.1021/acs.langmuir.8b03753 ↗
15. Lin, Q. K. et al. Heparin/collagen multilayer as a thromboresistant and endothelial favorable coating for intravascular stent. J. Biomed. Mater. Res., Part A 96A, 132–141 (2011).10.1002/jbm.a.32820 ↗
16. Kim, T. G., Lee, H., Jang, Y. & Park, T. G. Controlled Release of Paclitaxel from Heparinized Metal Stent Fabricated by Layer-by-Layer Assembly of Polylysine and Hyaluronic Acid-g-Poly(lactic-co-glycolic acid) Micelles Encapsulating Paclitaxel. Biomacromolecules 10, 1532–1539 (2009).10.1021/bm900116r ↗
17. Lamichhane, S., Gallo, A. & Mani, G. A Polymer-Free Paclitaxel Eluting Coronary Stent: Effects of Solvents, Drug Concentrations and Coating Methods. Ann. Biomed. Eng. 42, 1170–1184 (2014).10.1007/s10439-014-1003-y ↗
18. Alkekhia, D., Hammond, P. T. & Shukla, A. Layer-by-Layer Biomaterials for Drug Delivery. Annu. Rev. Biomed. Eng. 22, 1–24 (2020).10.1146/annurev-bioeng-060418-052350 ↗
19. Lee, H. J. et al. Improved blood compatibility and decreased VSMC proliferation of surface-modified metal grafted with sulfonated PEG or heparin. J. Biomater. Sci., Polym. Ed. 13, 939–952 (2002).10.1163/156856202320401979 ↗
20. Boissezon, R., Muller, J., Beaugeard, V., Monge, S. & Robin, J.-J. Organophosphonates as anchoring agents onto metal oxide-based materials: synthesis and applications. Rsc Adv. 4, 35690–35707 (2014).10.1039/C4RA05414H ↗
21. Raman, A., Dubey, M., Gouzman, I. & Gawalt, E. S. Formation of self-assembled monolayers of alkylphosphonic acid on the native oxide surface of SS316L. Langmuir 22, 6469–6472 (2006).10.1021/la060636p ↗
22. Raman, A. & Gawalt, E. S. Self-assembled monolayers of alkanoic acids on the native oxide surface of SS316L by solution deposition. Langmuir 23, 2284–2288 (2007).10.1021/la063089g ↗
23. Tosatti, S., Michel, R., Textor, M. & Spencer, N. D. Self-assembled monolayers of dodecyl and hydroxy-dodecyl phosphates on both smooth and rough titanium and titanium oxide surfaces. Langmuir 18, 3537–3548 (2002).10.1021/la011459p ↗
24. Slaney, A. M. et al. Biocompatible Carbohydrate-Functionalized Stainless Steel Surfaces: A New Method For Passivating Biomedical Implants. ACS Appl. Mater. Interfaces 3, 1601–1612 (2011).10.1021/am200158y ↗
25. Chan, J. W., Zhang, Y. Y. & Uhrich, K. E. Amphiphilic Macromolecule Self-Assembled Mono layers Suppress Smooth Muscle Cell Proliferation. Bioconjugate Chem. 26, 1359–1369 (2015).10.1021/acs.bioconjchem.5b00208 ↗
26. Kang, S. M. et al. One-Step Multipurpose Surface Functionalization by Adhesive Catecholamine. Adv. Funct. Mater. 22, 2949–2955 (2012).10.1002/adfm.201200177 ↗
27. Wang, J.-L. et al. Facile fabrication of robust superhydrophobic multilayered film based on bioinspired poly(dopamine)-modified carbon nanotubes. Phys. Chem. Chem. Phys. 16, 2936–2943 (2014).10.1039/c3cp54354d ↗
28. Chien, C.-Y. & Tsai, W.-B. Poly(dopamine)-Assisted Immobilization of Arg-Gly-Asp Peptides, Hydroxyapatite, and Bone Morphogenic Protein-2 on Titanium to Improve the Osteogenesis of Bone Marrow Stem Cells. ACS Appl. Mater. Interfaces 5, 6975–6983 (2013).10.1021/am401071f ↗
29. Yang, Z. L. et al. Mussel-inspired catalytic selenocystamine-dopamine coatings for long-term generation of therapeutic gas on cardiovascular stents. Biomaterials 178, 1–10 (2018).10.1016/j.biomaterials.2018.06.008 ↗
30. Wei, Q., Zhang, F., Li, J., Li, B. & Zhao, C. Oxidant-induced dopamine polymerization for multifunctional coatings. Polym. Chem. 1, 1430–1433 (2010).10.1039/c0py00215a ↗
31. Wang, J. L. et al. Electropolymerization of dopamine for surface modification of complex-shaped cardiovascular stents. Biomaterials 35, 7679–7689 (2014).10.1016/j.biomaterials.2014.05.047 ↗
32. Reilly, C. F., Fritze, L. M. & Rosenberg, R. D. Heparin inhibition of smooth muscle cell proliferation: a cellular site of action. J. Cell. Physiol. 129, 11–19 (1986).10.1002/jcp.1041290103 ↗
33. Koster, A. et al. Hemostatic activation and inflammatory response during cardiopulmonary bypass - Impact of heparin management. Anesthesiology 97, 837–841 (2002).10.1097/00000542-200210000-00014 ↗
34. Linhardt, R. J. 2003 Claude S. Hudson Award address in carbohydrate chemistry. Heparin: Structure and activity. J. Med. Chem. 46, 2551–2564 (2003).10.1021/jm030176m ↗
35. Grant, G. G. S., Koktysh, D. S., Yun, B. G., Matts, R. L. & Kotov, N. A. Layer-By-Layer Assembly of Collagen Thin Films: Controlled Thickness and Biocompatibility. Biomed. Microdevices 3, 301–306 (2001).10.1023/A:1012456714628 ↗
36. Fu, J., Ji, J., Fan, D. & Shen, J. Construction of antibacterial multilayer films containing nanosilver via layer-by-layer assembly of heparin and chitosan-silver ions complex. J. Biomed. Mater. Res., Part A 79A, 665–674 (2006).10.1002/jbm.a.30819 ↗
37. Hisham, F., Maziati Akmal, M. H., Ahmad, F., Ahmad, K. & Samat, N. Biopolymer chitosan: Potential sources, extraction methods, and emerging applications. Ain Shams Eng. J. 15, 102424 (2024).10.1016/j.asej.2023.102424 ↗
38. Chen, W. L., Habraken, T. C. J., Hennink, W. E. & Kok, R. J. Polymer-Free Drug-Eluting Stents: An Overview of Coating Strategies and Comparison with Polymer-Coated Drug-Eluting Stents. Bioconjugate Chem. 26, 1277–1288 (2015).10.1021/acs.bioconjchem.5b00192 ↗
39. Song, D., Hsu, L. F. & Au, J. L. S. Binding of taxol to plastic and glass containers and protein under in vitro conditions. J. Pharm. Sci. 85, 29–31 (1996).10.1021/js950286j ↗
40. Lee, B. H. et al. Paclitaxel-coated expanded polytetrafluoroethylene haemodialysis grafts inhibit neointimal hyperplasia in porcine model of graft stenosis. Nephrol., Dial., Transplant. 21, 2432–2438 (2006).10.1093/ndt/gfl070 ↗
41. Mani, G. et al. Delivery of paclitaxel from cobalt-chromium alloy surfaces without polymeric carriers. Biomaterials 31, 5372–5384 (2010).10.1016/j.biomaterials.2010.03.043 ↗
42. Belu, A., Mahoney, C. & Wormuth, K. Chemical imaging of drug eluting coatings: Combining surface analysis and confocal Raman microscopy. J. Controlled Release 126, 111–121 (2008).10.1016/j.jconrel.2007.11.015 ↗
43. Levy, Y., Khan, W., Farah, S. & Domb, A. J. Surface Crystallization of Rapamycin on Stents Using a Temperature Induced Process. Langmuir 28, 6207–6210 (2012).10.1021/la300364y ↗
44. Farah, S., Khan, W. & Domb, A. J. Crystalline coating of rapamycin onto a stent: Process development and characterization. Int. J. Pharm. 445, 20–28 (2013).10.1016/j.ijpharm.2013.01.053 ↗
45. Iakovou, I. et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA-J. Am. Med. Assoc. 293, 2126–2130 (2005).10.1001/jama.293.17.2126 ↗
46. Virmani, R., Farb, A., Guagliumi, G. & Kolodgie, F. D. Drug-eluting stents: caution and concerns for long-term outcome. Coron. Artery Dis. 15, 313–318 (2004).10.1097/00019501-200409000-00003 ↗
47. Virmani, R. et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent should we be cautious? Circulation 109, 701–705 (2004).10.1161/01.CIR.0000116202.41966.D4 ↗
48. Virmani, R., Kolodgie, F. D. & Farb, A. Drug-eluting stents: are they really safe? Am. heart hospital J. 2, 85–88 (2004).10.1111/j.1541-9215.2004.03632.x ↗
49. Nebeker, J. R. et al. Hypersensitivity cases associated with drug-eluting coronary stents - A review of available cases from the research on adverse drug events and reports (RADAR) project. J. Am. Coll. Cardiol. 47, 175–181 (2006).10.1016/j.jacc.2005.07.071 ↗
50. Ong, A. T. L. et al. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J. Am. Coll. Cardiol. 45, 2088–2092 (2005).10.1016/j.jacc.2005.02.086 ↗
51. Chan, J. W., Huang, A. & Uhrich, K. E. Self-Assembled Amphiphilic Macromolecule Coatings: Comparison of Grafting-From and Grafting-To Approaches for Bioactive Delivery. Langmuir 32, 5038–5047 (2016).10.1021/acs.langmuir.6b00524 ↗
52. Ulman, A. Formation and structure of self-assembled monolayers. Chem. Rev. 96, 1533–1554 (1996).10.1021/cr9502357 ↗
53. Mani, G. et al. Drug delivery from gold and titanium surfaces using self-assembled monolayers. Biomaterials 29, 4561–4573 (2008).10.1016/j.biomaterials.2008.08.014 ↗
54. Mani, G., Chandrasekar, B., Feldman, M. D., Patel, D. & Agrawal, C. M. Interaction of Endothelial Cells with Self-Assembled Monolayers for Potential Use in Drug-Eluting Coronary Stents. J. Biomed. Mater. Res., Part B 90B, 789–801 (2009).10.1002/jbm.b.31348 ↗
55. Ruan, C. M., Bayer, T., Meth, S. & Sukenik, C. N. Creation and characterization of n-alkylthiol and n-alkylamine self-assembled monolayers on 316L stainless steel. Thin Solid Films 419, 95–104 (2002).10.1016/S0040-6090(02)00730-7 ↗
56. Mahapatro, A. et al. The use of alkanethiol self-assembled monolayers on 316L stainless steel for coronary artery stent nanomedicine applications: an oxidative and in vitro stability study. Nanomed. -Nanotechnol. Biol. Med. 2, 182–190 (2006).10.1016/j.nano.2006.07.006 ↗
57. Mahapatro, A. et al. Drug delivery from therapeutic self-assembled monolayers (T-SAMs) on 316L stainless steel. Curr. Trends Med. Chem. 8, 281–289 (2008).10.2174/156802608783790929 ↗
58. Decher, G. & Hong, J. D. Buildup of ultrathin multilayer films by a self-assembly process, 1 consecutive adsorption of anionic and cationic bipolar amphiphiles on charged surfaces. Makromol. Chem.-Macromol. Symposia 46, 321–327 (1991).10.1002/masy.19910460145 ↗
59. Decher, G. & Hong, J. D. buildup of ultrathin multilayer films by a self-assembly process.2. consecutive adsorption of anionic and cationic bipolar amphiphiles and polyelectrolytes on charged surfaces. Ber. Bunsen-Ges. Phys. Chem. Chem. Phys. 95, 1430–1434 (1991).10.1002/bbpc.19910951122 ↗
60. Tang, Z. Y., Wang, Y., Podsiadlo, P. & Kotov, N. A. Biomedical applications of layer-by-layer assembly: From biomimetics to tissue engineering. Adv. Mater. 18, 3203–3224 (2006).10.1002/adma.200600113 ↗
61. Picart, C. Polyelectrolyte multilayer films: From physico-chemical properties to the control of cellular processes. Curr. Med. Chem. 15, 685–697 (2008).10.2174/092986708783885219 ↗
62. Yang, L. et al. A tailored extracellular matrix (ECM)-Mimetic coating for cardiovascular stents by stepwise assembly of hyaluronic acid and recombinant human type III collagen. Biomaterials 276, 121055 (2021).
63. Hong, S. et al. Non-covalent self-assembly and covalent polymerization co-contribute to polydopamine formation. Adv. Funct. Mater. 22, 4711–4717 (2012).10.1002/adfm.201201156 ↗
64. Lee, H., Dellatore, S. M., Miller, W. M. & Messersmith, P. B. Mussel-inspired surface chemistry for multifunctional coatings. Science 318, 426–430 (2007).10.1126/science.1147241 ↗
65. Fan, Y. H. et al. Immobilization of nano Cu-MOFs with polydopamine coating for adaptable gasotransmitter generation and copper ion delivery on cardiovascular stents. Biomaterials 204, 36–45 (2019).10.1016/j.biomaterials.2019.03.007 ↗
66. Tan, J. Y. et al. Heparin/poly-l-lysine nanoplatform with growth factor delivery for surface modification of cardiovascular stents: The influence of vascular endothelial growth factor loading. J. Biomed. Mater. Res.,Part A 108, 1295–1304 (2020).10.1002/jbm.a.36902 ↗
67. Ma, Q. et al. Durable endothelium-mimicking coating for surface bioengineering cardiovascular stents. Bioact. Mater. 6, 4786–4800 (2021).
68. Gu, X. N., Xie, X. H., Li, N., Zheng, Y. F. & Qin, L. In vitro and in vivo studies on a Mg–Sr binary alloy system developed as a new kind of biodegradable metal. Acta Biomater. 8, 2360–2374 (2012).10.1016/j.actbio.2012.02.018 ↗
69. Tang, H. et al. A surface-eroding poly(1,3-trimethylene carbonate) coating for magnesium based cardiovascular stents with stable drug release and improved corrosion resistance. Bioact. Mater. 7, 144–153 (2022).
70. Boodagh, P., Guo, D. J., Nagiah, N. & Tan, W. Evaluation of electrospun PLLA/PEGDMA polymer coatings for vascular stent material. J. Biomater. Sci. Polym. Ed. 27, 1086–1099 (2016).10.1080/09205063.2016.1176715 ↗
71. Strohbach, A. & Busch, R. Polymers for Cardiovascular Stent Coatings. Int. J. Polym. Sci. 2015, 782653 (2015).10.1155/2015/782653 ↗
72. Palanisamy, M. S., Kulandaivelu, R. & Nellaiappan, S. Improving the corrosion resistance and bioactivity of magnesium by a carbonate conversion-polycaprolactone duplex coating approach. N. J. Chem. 44, 4772–4785 (2020).10.1039/C9NJ06030H ↗
73. Jenney, C. R., DeFife, K. M., Colton, E. & Anderson, J. M. Human monocyte/macrophage adhesion, macrophage motility, and IL-4-induced foreign body giant cell formation on silane-modified surfaces in vitro. J. Biomed. Mater. Res 41, 171–184 (1998).10.1002/(SICI)1097-4636(199808)41:2<171::AID-JBM1>3.0.CO;2-F ↗
74. Kirchner, C. et al. Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles. Nano Lett. 5, 331–338 (2005).10.1021/nl047996m ↗
75. Liu, J. & Xi, T. Enhanced Anti-corrosion Ability and Biocompatibility of PLGA Coatings on MgZnYNd Alloy by BTSE-APTES Pre-treatment for Cardiovascular Stent. J. Mater. Sci. Technol. 32, 845–857 (2016).10.1016/j.jmst.2016.06.021 ↗
76. Shin, S. R. et al. Graphene-based materials for tissue engineering. Adv. Drug Deliv. Rev. 105, 255–274 (2016).10.1016/j.addr.2016.03.007 ↗
77. Tong, L. B. et al. Enhanced corrosion and wear resistances by graphene oxide coating on the surface of Mg-Zn-Ca alloy. Carbon 109, 340–351 (2016).10.1016/j.carbon.2016.08.032 ↗
78. Tatavarty, R., Ding, H., Lu, G., Taylor, R. J. & Bi, X. Synergistic acceleration in the osteogenesis of human mesenchymal stem cells by graphene oxide-calcium phosphate nanocomposites. Chem. Commun. 50, 8484–8487 (2014).10.1039/C4CC02442G ↗
79. Mei, Y. et al. Mapping the Interactions among Biomaterials, Adsorbed Proteins, and Human Embryonic Stem Cells. Adv. Mater. 21, 2781–2786 (2009).10.1002/adma.200803184 ↗
80. Bai, K. et al. Fabrication of chitosan/magnesium phosphate composite coating and the in vitro degradation properties of coated magnesium alloy. Mater. Lett. 73, 59–61 (2012).10.1016/j.matlet.2011.12.102 ↗
81. Gao, F. et al. Fabrication of chitosan/heparinized graphene oxide multilayer coating to improve corrosion resistance and biocompatibility of magnesium alloys. Mater. Sci. Eng. C. Mater. Biol. Appl 104, 109947 (2019).
82. Shao, C. et al. Mussel-Inspired Cellulose Nanocomposite Tough Hydrogels with Synergistic Self-Healing, Adhesive, and Strain-Sensitive Properties. Chem. Mater. 30, 3110–3121 (2018).10.1021/acs.chemmater.8b01172 ↗
83. Li, J.-a, Chen, L., Zhang, X.-q & Guan, S.-k. Enhancing biocompatibility and corrosion resistance of biodegradable Mg-Zn-Y-Nd alloy by preparing PDA/HA coating for potential application of cardiovascular biomaterials. Mater. Sci. Eng.: C. 109, 110607 (2020).10.1016/j.msec.2019.110607 ↗
84. Loriot, M., Linossier, I., Vallée-Réhel, K. & Faÿ, F. Influence of Biodegradable Polymer Properties on Antifouling Paints Activity. Polymers 9, 36 (2017).10.3390/polym9020036 ↗
85. Yang, M. C. et al. Electrochemical Polymerization of PEDOT-Graphene Oxide-Heparin Composite Coating for Anti-fouling and Anti-clotting of Cardiovascular Stents. Polymers 11, 1520 (2019).10.3390/polym11091520 ↗
86. Mori, Y. et al. A new antithrombogenic material with long polyethyleneoxide chains. Trans. Am. Soc. Artif. Intern Organs 28, 459–463 (1982).
87. Harder, P., Grunze, M., Dahint, R., Whitesides, G. M. & Laibinis, P. E. Molecular conformation in oligo(ethylene glycol)-terminated self-assembled monolayers on gold and silver surfaces determines their ability to resist protein adsorption. J. Phys. Chem. B 102, 426–436 (1998).10.1021/jp972635z ↗
88. Holmberg, K. et al. Effects on protein adsorption, bacterial adhesion and contact angle of grafting PEG chains to polystyrene. J. Adhes. Sci. Technol. 7, 503–517 (1993).10.1163/156856193X00826 ↗
89. Gombotz, W. R., Wang, G. H., Horbett, T. A. & Hoffman, A. S. Protein adsorption to poly(ethylene oxide) surfaces. J. Biomed. Mater. Res 25, 1547–1562 (1991).10.1002/jbm.820251211 ↗
90. Lee, H. J. et al. Platelet and bacterial repellence on sulfonated poly(ethylene glycol)-acrylate copolymer surfaces. Colloids Surf., B 18, 355–370 (2000).10.1016/S0927-7765(99)00161-7 ↗
91. Ko, Y. G. et al. Immobilization of poly(ethylene glycol) or its sulfonate onto polymer surfaces by ozone oxidation. Biomaterials 22, 2115–2123 (2001).10.1016/S0142-9612(00)00400-2 ↗
92. Puranik, A. S., Dawson, E. R. & Peppas, N. A. Recent advances in drug eluting stents. Int J. Pharm. 441, 665–679 (2013).10.1016/j.ijpharm.2012.10.029 ↗
93. Han, D. K., Jeong, S. Y., Kim, Y. H., Min, B. G. & Cho, H. I. Negative cilia concept for thromboresistance: synergistic effect of PEO and sulfonate groups grafted onto polyurethanes. J. Biomed. Mater. Res 25, 561–575 (1991).10.1002/jbm.820250502 ↗
94. Naghavi, N., de Mel, A., Alavijeh, O. S., Cousins, B. G. & Seifalian, A. M. Nitric oxide donors for cardiovascular implant applications. Small 9, 22–35 (2013).10.1002/smll.201200458 ↗
95. Scott, R. A. & Panitch, A. Macromolecular approaches to prevent thrombosis and intimal hyperplasia following percutaneous coronary intervention. Biomacromolecules 15, 2825–2832 (2014).10.1021/bm5007757 ↗
96. Rao, J. et al. Nitric Oxide-Producing Cardiovascular Stent Coatings for Prevention of Thrombosis and Restenosis. Front. Bioeng. Biotechnol. 8, 578 (2020).10.3389/fbioe.2020.00578 ↗
97. Halkin, A. & Stone, G. W. Polymer-Based Paclitaxel-Eluting Stents in Percutaneous Coronary Intervention. J. Interv. Cardiol. 17, 271–282 (2004).10.1111/j.1540-8183.2004.04040.x ↗
98. Rowinsky, E. K. & Donehower, R. C. Paclitaxel (Taxol). N. Engl. J. Med. 332, 1004–1014 (1995).10.1056/NEJM199504133321507 ↗
99. Ranade, S. V. et al. Physical characterization of controlled release of paclitaxel from the TAXUSTM Express2TM drug-eluting stent. J. Biomed. Mater. Res A 71, 625–634 (2004).10.1002/jbm.a.30188 ↗
100. Wiskirchen, J. et al. The effects of paclitaxel on the three phases of restenosis: smooth muscle cell proliferation, migration, and matrix formation: an in vitro study. Invest. Radiol. 39, 565–571 (2004).10.1097/01.rli.0000133815.22434.55 ↗